Starpharma

(ASX) SPL

Current Price$0.66

Market Cap$309.38M

Since IPO (2000)-8%

5 Year-59%

1 Year+642%

1 Month+23%

Starpharma Financials at a Glance

Market Cap

$309.38M

Revenue (TTM)

$18.41M

Net Income (TTM)

$15.75M

EPS (TTM)

$-0.01

P/E Ratio

-95.45

Dividend

$0.00

Beta (Volatility)

-0.02 (Low)

Dividend

$0.00

Beta (Volatility)

-0.02 (Low)

Price

$0.66

Volume

2,058,665

Open

$0.73

Price

$0.66

Volume

2,058,665

Open

$0.73

Previous Close

$0.66

Daily Range

$0.65 - $0.73

52-Week Range

$0.08 - $0.79

Dividend

$0.00

Beta (Volatility)

-0.02 (Low)

Price

$0.66

Volume

2,058,665

Open

$0.73

Previous Close

$0.66

Daily Range

$0.65 - $0.73

52-Week Range

$0.08 - $0.79

SPL News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Starpharma

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Cheryl Maley, MBA

Website

www.starpharma.com

Headquarters

Abbotsford, VIC 3067, AU

SPL Financials

Key Financial Metrics (TTM)

Gross Margin

60%

Operating Margin

-1%

Net Income Margin

-23%

Return on Equity

-14%

Return on Capital

-66%

Return on Assets

-12%

Earnings Yield

-1.05%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$309.38M

Shares Outstanding

420.93M

Volume

2.06M

Avg. Volume

1.69M

Financials (TTM)

Gross Profit

$3.69M

Operating Income

$12.00M

EBITDA

$10.93M

Operating Cash Flow

$6.76M

Capital Expenditure

$42.00K

Free Cash Flow

$6.80M

Cash & ST Invst.

$15.41M

Total Debt

$2.40M

Starpharma Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

$10.83M

+50.5%

Gross Profit

$10.04M

+56.2%

Gross Margin

92.68%

N/A

Market Cap

$309.38M

N/A

Market Cap/Employee

$7.73M

N/A

Employees

N/A

Net Income

$1.37M

+232.2%

EBITDA

$3.53M

+0.6%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Net Cash

$17.46M

-39.8%

Accounts Receivable

$4.17M

-11.0%

Inventory

$1.82M

-32.7%

Long Term Debt

$0.00

-100.0%

Short Term Debt

$790.00K

+3.1%

Return on Assets

-12.35%

N/A

Return on Invested Capital

-66.23%

N/A

Free Cash Flow

$3.67M

+75.9%

Operating Cash Flow

$3.91M

+86.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

EMV.AXEMVision Medical Devices Ltd

EMV.AXEMVision Medical Devices Ltd$1.80-2.70%

ACW.AXActinogen Medical Limited

ACW.AXActinogen Medical Limited$0.04-2.33%

ONE.AXOneview Healthcare PLC

ONE.AXOneview Healthcare PLC$0.17+0.00%

RCE.AXRecce Pharmaceuticals Ltd

RCE.AXRecce Pharmaceuticals Ltd$0.47-4.08%

ATH.AXAlterity Therapeutics Limited

ATH.AXAlterity Therapeutics Limited$0.01+0.00%

NYR.AXNyrada Inc.

NYR.AXNyrada Inc.$0.54-1.82%

ALA.AXArovella Therapeutics Limited

ALA.AXArovella Therapeutics Limited$0.07+2.74%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AIIORobo.ai

AIIORobo.ai$6.13+1.35%

NOKNokia

NOKNokia$14.59-0.01%

POETPoet Technologies

POETPoet Technologies$20.16+0.40%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$16.93+0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$79.30+0.03%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.86-0.03%

EOSEEos Energy Enterprises

EOSEEos Energy Enterprises$8.12-0.02%

Questions About SPL

What is the current price of Starpharma?

Starpharma is trading at A$0.66 per share.

What is the 52-week range for Starpharma?

Over the past 52 weeks, Starpharma has traded between A$0.08 and A$0.79.

How much debt does Starpharma have?

As of the most recent reporting period, Starpharma reported total debt of $2.40M.

How much cash does Starpharma have on hand?

Starpharma reported $15.41M in cash and cash equivalents in its most recent financial results.

What is Starpharma’s dividend yield?

Starpharma does not currently have a dividend yield.

Starpharma

Starpharma Financials at a Glance

SPL News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Starpharma

SPL Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Starpharma Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About SPL

What is the current price of Starpharma?

What is the 52-week range for Starpharma?

How much debt does Starpharma have?

How much cash does Starpharma have on hand?

What is Starpharma’s dividend yield?

Premium Investing Services